ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • 2026 ACR/ARP PRSYM
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 006

Age Matters: Clinical Profile and IVIG Responsiveness in infants with Kawasaki Disease. A multicentric retrospective analysis of 36 patients from North India

Abhay Shivpuri1, manjari Agarwal2 and sujata Sawhney3, 1Neoclinic Children's Hospital, Jaipur, Rajasthan, India, 2Sir Ganga Ram Hospital, NEW DELHI, Delhi, India, 3Sir Ganga Ram Hospital, Sector 37 noida, Uttar Pradesh, India

Meeting: 2026 Pediatric Rheumatology Symposium

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, March 19, 2026

Title: Posters: Clinical and Therapeutic Aspects I

Session Time: 6:00PM-7:00PM

Background/Purpose: Kawasaki disease (KD) is a systemic medium vessel vasculitis that is predominantly a clinical diagnosis as defined by the American Heart Association (AHA). KD is the most common cause of acquired heart disease in children with 25% of untreated cases developing coronary artery aneurysms (CAAs). Majority of cases occur in children < 5 years of age. In younger infants, the immune system is immature and classic symptoms of KD are often absent leading to a misdiagnosis or delay in diagnosis. This is the age group where chances of CAA are highest. Complications of CAA include stenosis formation, coronary thrombosis, myocardial infarction, and sudden death. Giant aneurysms  have fatal risk of rupture. In this study, we identified infants with KD 6 months or younger and compared them to those over 6 months.

Methods: Retrospective multicentric observational study of infants ≤12 months diagnosed with KD.  Patients included from 2 centres: Neoclinic Children’s Hospital, Jaipur and Sir Ganga Ram Hospital, New Delhi between April 2019 to June 2025. Diagnosis was based on AHA  2017 or  clinical for incomplete KD. 2D ECHO done by different Paediatric cardiologists on different ECHO machines; CAA z scores  calculated using either Dallaire and Dahdah or Boston formula. Data collected included demographics, clinical features, echocardiography findings & treatment outcomes. Continuous variables summarized using medians and ranges; categorical variables summarized as counts and percentages. Categorical variables analysed using Fisher’s Exact Test. Continuous variables compared using Mann-Whitney U test. Statistical significance defined as p < 0.05. Analysis performed using standard SPSS statistical software.

Results: Younger Infants< 6 mnths (Group A) had significantly higher rates of abnormal CAA (94.4%) compared to older infants (Group B) (61.1%), with significant differences in CAA  favouring Group B (p ≈ 0.04). Incomplete KD present in all infants of Group A (100%) and 12/18 (66.7%) in Group B. Median age at onset 3 months in Group A vs. 10 months in Group B. Median delay in diagnosis similar (11.5 vs 12.5 days). Fever & irritability universal in both groups. Certain features, such as red dry lips, were more common in Group B (12/18) than Group A (5/18) with p = 0.044. Other clinical symptoms showed no significant differences. Male predominance was higher in Group B compared to Group A. Rates of primary intensification and steroid-resistant disease after intensification were similar in both groups. The proportion of infants managed with only IVIG and moderate dose aspirin who were resistant was comparable ( Table 1).Median delay in diagnosis more with worse CAA & those infants required primary intensification(Table 2).

Conclusion: Almost all infants presented with incomplete disease (fever and irritability predominant) often leading to delay in diagnosis & high risk for CAA & long term cardiac sequale. The distribution showed a greater proportion of normal coronaries in older infants; infants < 6months  had more CAA with Z score >2.5 indicative of higher disease burden. Pediatricians need to identify infants requiring earlier and more aggressive intervention. Larger studies with Indian infants are required to confirm these findings.

Clinical profile of infants with KD younger than 6 months (group A) compared to 7-12months (Group B)Supporting image 1

Comparison of infants with normal-small aneurysms with medium-large aneurysmsSupporting image 2


Disclosures: A. Shivpuri: None; m. Agarwal: None; s. Sawhney: None.

To cite this abstract in AMA style:

Shivpuri A, Agarwal m, Sawhney s. Age Matters: Clinical Profile and IVIG Responsiveness in infants with Kawasaki Disease. A multicentric retrospective analysis of 36 patients from North India [abstract]. Arthritis Rheumatol. 2026; 78 (suppl 3). https://acrabstracts.org/abstract/age-matters-clinical-profile-and-ivig-responsiveness-in-infants-with-kawasaki-disease-a-multicentric-retrospective-analysis-of-36-patients-from-north-india/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to 2026 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/age-matters-clinical-profile-and-ivig-responsiveness-in-infants-with-kawasaki-disease-a-multicentric-retrospective-analysis-of-36-patients-from-north-india/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology